An international team of researchers including scientists from The Australian National University (ANU) have developed a way ...
Researchers in Class of 1942 Professor of Chemistry Matthew D. Shoulders' lab have uncovered a sinister hidden mechanism that ...
Researchers have identified a mechanism which can explain aspects of neurodegeneration which have baffled scientists for ...
News-Medical.Net on MSN
Gene therapy targeting connexin 43 shows promise across inherited heart diseases
University of California San Diego-led team has discovered that restoring a key cardiac protein called connexin‑43 in a mouse ...
Researchers at Nano Life Science Institute (WPI-NanoLSI) and the Cancer Research Institute at Kanazawa University have ...
News Medical on MSN
New atlas of brain lysosomes sheds light on neurodegenerative disorders
Functioning brain cells need a functioning system for picking up the trash and sorting the recycling. But when the cellular ...
Scientists have long known that inherited neurodegenerative disorders, including Alzheimer's, Parkinson's or motor neuron ...
A research team engineered a rigid, nanometer-scale protein module to address the challenge of measuring antibody flexibility ...
Researchers at Nano Life Science Institute (WPI-NanoLSI) and the Cancer Research Institute at Kanazawa University led have uncovered how targeted lung cancer drugs alter the shape and behavior of a ...
A new experimental vaccine could slow down triple negative breast cancer and reduce its recurrence after treatment.
Scientists at Johns Hopkins have uncovered a surprising new way to influence brain activity by targeting a long-mysterious class of proteins linked to anxiety, schizophrenia, and movement disorders.
Mutations in the tumor suppressor TP53 are a common cause of cancer, making the altered protein an attractive target for therapeutics. Among them, the Y220C mutation is the ninth most frequent and it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results